zurniimtpeМедицина труда и промышленная экологияRussian Journal of Occupational Health and Industrial Ecology1026-94282618-8945FSBSI “Izmerov Research Institute of Occupational Health”zurniimtpe-661Research ArticleСтатьиЛечение больных псориазом с сопутствующим метаболическим синдромом препаратами биологической терапии: предикторы эффективности и потенциальные риски (обзор литературы)Preparations in treatment of psoriasis patients with concurrent metabolic syndrome: efficiency predictors and potential risks (review of literature)Росете-ПидальЕ. А.Rosete-PidalE. A.org@cgma.suКругловаЛ. С.KruglovaL. S.kruglovals@mail.ruПоничЕ. С.PonichE. S.org@cgma.suЧорбинскаяС. А.ChorbinskajaS. A.kaffizio@gmail.comФилатоваЕ. В.FilatovaE. V.kaffizio@gmail.comФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента РФРоссияCentral state medical academy of department of presidential affairs of the Russian FederationRussian Federation201701082017083336Copyright © Росете-Пидаль Е.А., Круглова Л.С., Понич Е.С., Чорбинская С.А., Филатова Е.В., 20172017Росете-Пидаль Е.А., Круглова Л.С., Понич Е.С., Чорбинская С.А., Филатова Е.В.Rosete-Pidal E.A., Kruglova L.S., Ponich E.S., Chorbinskaja S.A., Filatova E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.journal-irioh.ru/jour/article/view/661

В обзоре освещены литературные данные о лечении больных псориазом с коморбидным метаболическим синдромом препаратами генно-инженерной биологической терапии (ГИБТ). Особое внимание уделено показаниям к назначению ГИБТ, дифференцированному подбору препаратов данной категории больных для снижения рисков ухудшения заболевания.

The review covers literature data on treatment of psoriasis patients with concurrent metabolic syndrome by genetic engineering preparations of biologic therapy. Special attention is paid to indications for genetic engineering preparations of biologic therapy, differential selection of such preparations for patients to decrease risks of the disease deterioration.

псориазкоморбидностиметаболический синдромгенно-инженерная биологическая терапияpsoriasiscomorbiditymetabolic syndromegenetic engineering preparations of biologic therapyReferencesБутрова С.А., Дзгоева Ф.Х. Висцеральное ожирение - ключевое звено метаболического синдрома // Ожирение и метаболизм. - 2004. - № 1. - С. 10-16Бутрова С.А., Дзгоева Ф.Х. Висцеральное ожирение - ключевое звено метаболического синдрома // Ожирение и метаболизм. - 2004. - № 1. - С. 10-16Дегтярев О.В., Меснянкина О. А. Патогенетическая роль нарушений липидного профиля при псориазе // Росс. ж-л кожных и венерич. болезней. - 2015. - № 18 (1). - С. 30-33.Дегтярев О.В., Меснянкина О. А. Патогенетическая роль нарушений липидного профиля при псориазе // Росс. ж-л кожных и венерич. болезней. - 2015. - № 18 (1). - С. 30-33.Кочергин Н.Г., Потекаев Н.Н., Смирнова Л.М., Серов Д.Н., Олисова О.Ю., Бабушкин А.М. Наш первый опыт применения адалинумаба при псориазе. // Росс. ж-л кожных и венерич. болезней. - 2012. - № 5. - С. 37-41.Кочергин Н.Г., Потекаев Н.Н., Смирнова Л.М., Серов Д.Н., Олисова О.Ю., Бабушкин А.М. Наш первый опыт применения адалинумаба при псориазе. // Росс. ж-л кожных и венерич. болезней. - 2012. - № 5. - С. 37-41.Кунгуров Н.В., Филимонкова Н.Н., Голубцов В.И., Корхмазова С.А. Генетические факторы этиологии и патогенеза псориаза // Вестн. дерматологии и венерологии. - 2011. - № 1. - С. 23-27.Кунгуров Н.В., Филимонкова Н.Н., Голубцов В.И., Корхмазова С.А. Генетические факторы этиологии и патогенеза псориаза // Вестн. дерматологии и венерологии. - 2011. - № 1. - С. 23-27.Потекаев Н.Н., Круглова Л.С. Псориатическая болезнь. - М.: МДВ, 2014. - 264 с.Потекаев Н.Н., Круглова Л.С. Псориатическая болезнь. - М.: МДВ, 2014. - 264 с.Фалько Е.В., Хышиктуев Б.С. Нарушения липидного обмена при псориатической болезни // Дальневост. мед. ж-л. - 2009. - № 2. - С. 118-122.Фалько Е.В., Хышиктуев Б.С. Нарушения липидного обмена при псориатической болезни // Дальневост. мед. ж-л. - 2009. - № 2. - С. 118-122.Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. - 5-е изд. - М.: Деловой экспресс, 2016. - 768 с.Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. - 5-е изд. - М.: Деловой экспресс, 2016. - 768 с.Al-Mutairi N., Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial // Expert Opinion on Biological Therapy. - 2014. - 14 (6). - 749-756.Al-Mutairi N., Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial // Expert Opinion on Biological Therapy. - 2014. - 14 (6). - 749-756.Armstrong A.W., Robertson A.D., Wu J., Schupp C., Lebwohl M.G. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011 // JAMA Dermatol. - 2013. - 149 (10). - P. 1180-1185.Armstrong A.W., Robertson A.D., Wu J., Schupp C., Lebwohl M.G. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011 // JAMA Dermatol. - 2013. - 149 (10). - P. 1180-1185.Augustin M., Reich K., Glaeske G., Schaefer I., Radtke M. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany // ActaDermato - Venereologica. - 2010. - 90 (2). - P. 147-151.Augustin M., Reich K., Glaeske G., Schaefer I., Radtke M. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany // ActaDermato - Venereologica. - 2010. - 90 (2). - P. 147-151.Baltabayev M.A. Immun system and bile acids metabolism in psoriatic patients. 20th World Congress of Dermatology: Paris. - 2002. - book II, 1S750: abstr. 1941.Baltabayev M.A. Immun system and bile acids metabolism in psoriatic patients. 20th World Congress of Dermatology: Paris. - 2002. - book II, 1S750: abstr. 1941.Boehncke W.H., Boehncke S. Research in practice: the systemic aspects of psoriasis // J. Dtsch. Dermatol. Ges. - 2008. - 6 (8). - P. 622-625.Boehncke W.H., Boehncke S. Research in practice: the systemic aspects of psoriasis // J. Dtsch. Dermatol. Ges. - 2008. - 6 (8). - P. 622-625.Del Giglio M., Gisondi P., Tessari G., Girolomoni G. Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study // Dermatology. - 2012. - 224. - P. 31-37.Del Giglio M., Gisondi P., Tessari G., Girolomoni G. Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study // Dermatology. - 2012. - 224. - P. 31-37.Drateln C.R., Martines-Abundis E., Balcazar-Munor B.R., Bustos-Saldana R., Gonzales-Ortis M. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis // J. Am. Acad. Dermatol. - 2003. - 48 (6). - P. 882-885.Drateln C.R., Martines-Abundis E., Balcazar-Munor B.R., Bustos-Saldana R., Gonzales-Ortis M. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis // J. Am. Acad. Dermatol. - 2003. - 48 (6). - P. 882-885.Farber E.M., Nall M.L. The natural history of psoriasis in 5,600 patients // Dermatologica. - 1974. - 148 (1). - P. 1-18.Farber E.M., Nall M.L. The natural history of psoriasis in 5,600 patients // Dermatologica. - 1974. - 148 (1). - P. 1-18.Fry L. Psoriasis. British Journal of Dermatology. - 1988. - 119 (4). - P. 445-461.Fry L. Psoriasis. British Journal of Dermatology. - 1988. - 119 (4). - P. 445-461.Gelfand J.M., Stern R.S., Nijsten T., Feldman S.R., Thomas J., Kist J., Rolstad T., Margolis D.J. The prevalence of psoriasis in African Americans: results from a population-based study // Journal of the American Academy of Dermatology. - 2005. - 52 (1). - P. 23-26.Gelfand J.M., Stern R.S., Nijsten T., Feldman S.R., Thomas J., Kist J., Rolstad T., Margolis D.J. The prevalence of psoriasis in African Americans: results from a population-based study // Journal of the American Academy of Dermatology. - 2005. - 52 (1). - P. 23-26.Gisondi P., Conti A., Galdo G., Piaserico S., De Simone C., Girolomoni G. Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study // British J of Dermatology. - 2013. - 168 (5). - P. 1124-1127.Gisondi P., Conti A., Galdo G., Piaserico S., De Simone C., Girolomoni G. Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study // British J of Dermatology. - 2013. - 168 (5). - P. 1124-1127.Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis // The Lancet. - 2007. - 370 (9583). - P. 263271.Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis // The Lancet. - 2007. - 370 (9583). - P. 263271.Guenther L., Gulliver W. Psoriasis comorbidities // J Of Cutaneous Medicine And Surgery. - 2009. - 13 (2). - P. 77-87.Guenther L., Gulliver W. Psoriasis comorbidities // J Of Cutaneous Medicine And Surgery. - 2009. - 13 (2). - P. 77-87.Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., Krueger G.G. Impact of obesity and smoking on psoriasis presentation and management // Archives of Dermatology. - 2005. - 141 (12). - P. 1527-1534.Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., Krueger G.G. Impact of obesity and smoking on psoriasis presentation and management // Archives of Dermatology. - 2005. - 141 (12). - P. 1527-1534.Holzer M., Wolf P., Inzinger M., Trieb M., Curcic S., Pasterk L., Weger W., Heinemann A., Marsche G. Anti-psoriatic therapy recovers high-density lipoprotein composition and function // J of Investigative Dermatology. - 2014. - 134 (3). - P. 635-642.Holzer M., Wolf P., Inzinger M., Trieb M., Curcic S., Pasterk L., Weger W., Heinemann A., Marsche G. Anti-psoriatic therapy recovers high-density lipoprotein composition and function // J of Investigative Dermatology. - 2014. - 134 (3). - P. 635-642.Johnson-Huang L.M., Lowes M.A., Krueger J.G. Putting together the psoriasis puzzle: an update on developing targeted therapies // Disease Models and Mechanisms. - 2012. - 5. P. 423-433.Johnson-Huang L.M., Lowes M.A., Krueger J.G. Putting together the psoriasis puzzle: an update on developing targeted therapies // Disease Models and Mechanisms. - 2012. - 5. P. 423-433.Kacalak-Rzepka A., Kiedrowicz M., Maleszka R. Analysis of the chosen parameters of metabolic status in patients with psoriasis // Ann. Acad. Med. Stetin. - 2013. - 59 (2). - P. 12-17.Kacalak-Rzepka A., Kiedrowicz M., Maleszka R. Analysis of the chosen parameters of metabolic status in patients with psoriasis // Ann. Acad. Med. Stetin. - 2013. - 59 (2). - P. 12-17.Kimball А.В., Leonardi С., Stahle М., Gulliver W., Chevrier M., Fakharzadeh S., Goyal K., Calabro S., Langholff W., Menter A. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR) // British J of Dermatology. - 2014. - 171 (1) - P. 137-147.Kimball А.В., Leonardi С., Stahle М., Gulliver W., Chevrier M., Fakharzadeh S., Goyal K., Calabro S., Langholff W., Menter A. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR) // British J of Dermatology. - 2014. - 171 (1) - P. 137-147.Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey // Archives of Dermatology. - 2001. - 137 (3). - P. 280-284.Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey // Archives of Dermatology. - 2001. - 137 (3). - P. 280-284.Love T.J., Qureshi A.A., Karlson E.W., Gelfand J.M., Choi H.K. et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006 // Arch. Dermatol. - 2011. - 147 (4). - P. 419-424.Love T.J., Qureshi A.A., Karlson E.W., Gelfand J.M., Choi H.K. et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006 // Arch. Dermatol. - 2011. - 147 (4). - P. 419-424.Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities // The J of Clinical Investigation. - 2004. - 113 (12). - P. 1664-1675.Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities // The J of Clinical Investigation. - 2004. - 113 (12). - P. 1664-1675.Pietrzak J., Chodorowska G. Psoriasis and serum lipid abnormalities // Dermatologic Therapy. - 2010. - 23 (2). - P. 160-173.Pietrzak J., Chodorowska G. Psoriasis and serum lipid abnormalities // Dermatologic Therapy. - 2010. - 23 (2). - P. 160-173.Sinead M. Langan, Nicole M. Seminara, Daniel B. Shin, Andrea B. Troxel, Stephen E. Kimmel, Nehal N. Mehta, David J. Margolis, Joel M. Gelfand. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom // J of Investigative Dermatology. - 2012. - 132. - P. 556-562.Sinead M. Langan, Nicole M. Seminara, Daniel B. Shin, Andrea B. Troxel, Stephen E. Kimmel, Nehal N. Mehta, David J. Margolis, Joel M. Gelfand. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom // J of Investigative Dermatology. - 2012. - 132. - P. 556-562.Sterry W., Strober B. E., Menter A.; International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review // British J of Dermatology. - 2007. - 157 (4). - P. 649-655.Sterry W., Strober B. E., Menter A.; International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review // British J of Dermatology. - 2007. - 157 (4). - P. 649-655.Torii H., Nakagawa H. Questionnaire survey of perceived satisfaction with treatment of patients with psoriasis // The Japanese J of Dermatology. - 2013. - 123. - P. 1935-1944.Torii H., Nakagawa H. Questionnaire survey of perceived satisfaction with treatment of patients with psoriasis // The Japanese J of Dermatology. - 2013. - 123. - P. 1935-1944.

The authors declare that there are no conflicts of interest present.